Literature DB >> 15694844

Biological response of human diploid keratinocytes to quinone-producing compounds: role of NAD(P)H:quinone oxidoreductase 1.

Cesira Foppoli1, Federico De Marco, Carla Blarzino, Marzia Perluigi, Chiara Cini, Raffaella Coccia.   

Abstract

Reactive oxygen species (ROS) and quinones are known to determine redox balance alteration, oxidative stress and carcinogenicity. Keratinocytes of the human epidermis, a tissue particularly exposed to oxidant stimuli, possess a wide range of antioxidant and detoxifying mechanisms aimed to avoid oxidative damage of the tissue. In the present study, we evaluate the response of diploid and transformed human keratinocytes to exposure to L-dopa and tetrahydropapaveroline (THP), catechol compounds susceptible to undergo oxidation to form quinones with concomitant production of reactive oxygen species. We demonstrated that these compounds elicit up-regulation of intracellular antioxidant enzymes, in a different degree in normal cells with respect to transformed ones. Normal diploid keratinocytes adequately scavenge toxic substances through the activation of several, concurrent pathways. Conversely, in transformed cells, the whole oxidative burden must be detoxified by the limited set of conserved pathways that, accordingly, have to be highly activated. The biological response to catechol toxicity appears to rely on the pathway of NAD(P)H:quinone oxidoreductase 1 (NQO1). In conclusion, NAD(P)H:quinone oxidoreductase 1 confirms its antioxidant and detoxifying role contributing to the capacity of keratinocytes to protect epidermis against oxidative stress. Being retained in almost any cell, it represents a mechanism of general relevance in cell physiology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15694844     DOI: 10.1016/j.biocel.2004.11.002

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  7 in total

1.  Bach1 overexpression in Down syndrome correlates with the alteration of the HO-1/BVR-a system: insights for transition to Alzheimer's disease.

Authors:  Fabio Di Domenico; Gilda Pupo; Cesare Mancuso; Eugenio Barone; Francesca Paolini; Andrea Arena; Carla Blarzino; Frederick A Schmitt; Elizabeth Head; D Allan Butterfield; Marzia Perluigi
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

2.  Design, synthesis, and biological evaluation of callophycin A and analogues as potential chemopreventive and anticancer agents.

Authors:  Li Shen; Eun-Jung Park; Tamara P Kondratyuk; Daniela Guendisch; Laura Marler; John M Pezzuto; Anthony D Wright; Dianqing Sun
Journal:  Bioorg Med Chem       Date:  2011-09-16       Impact factor: 3.641

3.  Tert-butylhydroquinone ameliorates doxorubicin-induced cardiotoxicity by activating Nrf2 and inducing the expression of its target genes.

Authors:  Lin-Feng Wang; Su-Wen Su; Lei Wang; Guo-Qiang Zhang; Rong Zhang; Yu-Jie Niu; Yan-Su Guo; Chun-Yan Li; Wen-Bo Jiang; Yi Liu; Hui-Cai Guo
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

4.  Neurotoxic effects of tetrahydroisoquinolines and underlying mechanisms.

Authors:  Young-Joon Surh; Hyun-Jung Kim
Journal:  Exp Neurobiol       Date:  2010-09-30       Impact factor: 3.261

5.  Cell Fate following Irradiation of MDA-MB-231 and MCF-7 Breast Cancer Cells Pre-Exposed to the Tetrahydroisoquinoline Sulfamate Microtubule Disruptor STX3451.

Authors:  Scott D Hargrave; Anna M Joubert; Barry V L Potter; Wolfgang Dohle; Sumari Marais; Anne E Mercier
Journal:  Molecules       Date:  2022-06-14       Impact factor: 4.927

6.  Expression of human papilloma virus type 16 E5 protein in amelanotic melanoma cells regulates endo-cellular pH and restores tyrosinase activity.

Authors:  Fabio Di Domenico; Cesira Foppoli; Carla Blarzino; Marzia Perluigi; Francesca Paolini; Salvatrice Morici; Raffaella Coccia; Chiara Cini; Federico De Marco
Journal:  J Exp Clin Cancer Res       Date:  2009-01-08

7.  Changes in iron metabolism and oxidative status in STZ-induced diabetic rats treated with bis(maltolato) oxovanadium (IV) as an antidiabetic agent.

Authors:  Cristina Sánchez-González; Carlos López-Chaves; Cristina E Trenzado; Pilar Aranda; María López-Jurado; Jorge Gómez-Aracena; María Montes-Bayón; Alfredo Sanz-Medel; Juan Llopis
Journal:  ScientificWorldJournal       Date:  2014-01-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.